Relationships between hypertensive disorders in pregnancy and obstructive sleep apnea syndrome.
10.3760/cma.j.cn112141-20230219-00074
- Author:
Rui BAI
1
;
Jing Yu WANG
2
;
Chi ZHANG
2
;
Shen Da HONG
3
;
Lin Yan ZHANG
1
;
Jun WEI
1
;
Yan WANG
1
;
Jing Jing YANG
1
;
Xiao Song DONG
2
;
Fang HAN
2
;
Guo Li LIU
1
Author Information
1. Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China.
2. Division of Sleep Medicine, Peking University People's Hospital, Beijing 100044, China.
3. National Institute of Health Data Science, Peking University, Beijing 100191, China.
- Publication Type:Journal Article
- MeSH:
Infant, Newborn;
Pregnancy;
Infant;
Humans;
Female;
Pre-Eclampsia/epidemiology*;
Hypertension, Pregnancy-Induced/epidemiology*;
Retrospective Studies;
Premature Birth;
Sleep Apnea, Obstructive/epidemiology*;
Diabetes, Gestational/epidemiology*
- From:
Chinese Journal of Obstetrics and Gynecology
2023;58(9):658-663
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To investigate the impact of obstructive sleep apnea syndrome (OSAS) on pregnancy outcomes, especially the relationship between OSAS and hypertensive disorders in pregnancy (HDP). Methods: A total of 228 pregnant women with high risk of OSAS who underwent sleep monitoring during pregnancy in Peking University People's Hospital from January 2021 to April 2022 were collected by reviewing their medical records for retrospective analysis. According to the diagnosis of OSAS, the pregnant women were divided into OSAS group (105 cases) and non-OSAS group (123 cases). The non-parametric Mann-Whitney U test, χ2 test or Fisher's exact test were used to compare the general data and maternal and fetal outcomes between the two groups, and the occurrence of each type of HDP was further compared. Results: (1) Compared with the non-OSAS group, the median pre-pregnancy body mass index (23.6 vs 27.6 kg/m2) and the proportion of snoring [28.9% (33/114) vs 59.2% (61/103)] in the OSAS group were higher, and the differences were both statistically significant (both P<0.001). (2) The incidence of HDP [67.6% (71/105) vs 39.0% (48/123)] and gestational diabetes mellitus [GDM; 40.0% (42/105) vs 26.8% (33/123)] of pregnant women in the OSAS group were higher than those in the non-OSAS group, and the median delivery week was shorter than that in the non-OSAS group (38.4 vs 39.0 weeks). The differences were all statistically significant (all P<0.05). Between-group differences for the delivery way, postpartum hemorrhage, the rate of intensive care unit admission, preterm birth, small for gestational age infants, neonatal asphyxia, the rate of neonatal intensive care unit admission, newborn birth weight and the proportion of umbilical artery blood pH<7.00 were not statistically significant (all P>0.05). (3) Compared with the non-OSAS group, the incidence of chronic hypertension [11.4% (14/123) vs 22.9% (24/105)] and chronic hypertension with superimposed pre-eclampsia [11.4% (14/123) vs 30.5% (32/105)] were higher in the OSAS group, and the differences were both statistically significant (both P<0.01). Conclusion: OSAS is related to HDP (especially chronic hypertension and chronic hypertension with superimposed pre-eclampsia) and GDM, which could provide a practical basis for the screening, diagnosis and treatment of OSAS in pregnant women at high risk.
